Review



p eif2a af705  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems p eif2a af705
    Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, <t>p-eIF2a,</t> and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.
    P Eif2a Af705, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 15 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+eif2a+af705/pmc05958802-190-5-13?v=R%26D+Systems
    Average 93 stars, based on 15 article reviews
    p eif2a af705 - by Bioz Stars, 2026-08
    93/100 stars

    Images

    1) Product Images from "Significance of calreticulin as a prognostic factor in endometrial cancer"

    Article Title: Significance of calreticulin as a prognostic factor in endometrial cancer

    Journal: Oncology Letters

    doi: 10.3892/ol.2018.8495

    Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, p-eIF2a, and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.
    Figure Legend Snippet: Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, p-eIF2a, and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.

    Techniques Used: Immunohistochemical staining, Staining, Immunostaining

    Relationship between CRT, p-eIF2a, Ki67 expression and clinicopathological features of endometrial cancer.
    Figure Legend Snippet: Relationship between CRT, p-eIF2a, Ki67 expression and clinicopathological features of endometrial cancer.

    Techniques Used: Expressing

    Relationship between CRT, eIF-2a, Ki67 expression and clinicopathological features of endometrial carcinoma patients with NAC.
    Figure Legend Snippet: Relationship between CRT, eIF-2a, Ki67 expression and clinicopathological features of endometrial carcinoma patients with NAC.

    Techniques Used: Expressing

    Association between CRT, eIF-2a, Ki67 expression and clinicopathological features of advanced endometrial cancer patients after NAC.
    Figure Legend Snippet: Association between CRT, eIF-2a, Ki67 expression and clinicopathological features of advanced endometrial cancer patients after NAC.

    Techniques Used: Expressing



    Similar Products

    p eif2a af705  (R&D Systems)
    93
    R&D Systems p eif2a af705
    Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, <t>p-eIF2a,</t> and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.
    P Eif2a Af705, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+eif2a+af705/pmc05958802-190-5-13?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    p eif2a af705 - by Bioz Stars, 2026-08
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, p-eIF2a, and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.

    Journal: Oncology Letters

    Article Title: Significance of calreticulin as a prognostic factor in endometrial cancer

    doi: 10.3892/ol.2018.8495

    Figure Lengend Snippet: Representative photomicrographs of immunohistochemical staining of endometrial cancer specimens with anti-CRT, p-eIF2a, and Ki67 antibody. Immunostaining for (A) CRT, (B) p-eIF2a, and (C) Ki67 in endometrial cancer cells. CRT, calreticulin; p-eIF2α, phosphorylated eukaryotic initiation factor 2α.

    Article Snippet: Primary antibodies against CRT (MAB3898), p-eIF2a (AF705) and PERK (AF3999) were purchased from R&D systems.

    Techniques: Immunohistochemical staining, Staining, Immunostaining

    Relationship between CRT, p-eIF2a, Ki67 expression and clinicopathological features of endometrial cancer.

    Journal: Oncology Letters

    Article Title: Significance of calreticulin as a prognostic factor in endometrial cancer

    doi: 10.3892/ol.2018.8495

    Figure Lengend Snippet: Relationship between CRT, p-eIF2a, Ki67 expression and clinicopathological features of endometrial cancer.

    Article Snippet: Primary antibodies against CRT (MAB3898), p-eIF2a (AF705) and PERK (AF3999) were purchased from R&D systems.

    Techniques: Expressing

    Relationship between CRT, eIF-2a, Ki67 expression and clinicopathological features of endometrial carcinoma patients with NAC.

    Journal: Oncology Letters

    Article Title: Significance of calreticulin as a prognostic factor in endometrial cancer

    doi: 10.3892/ol.2018.8495

    Figure Lengend Snippet: Relationship between CRT, eIF-2a, Ki67 expression and clinicopathological features of endometrial carcinoma patients with NAC.

    Article Snippet: Primary antibodies against CRT (MAB3898), p-eIF2a (AF705) and PERK (AF3999) were purchased from R&D systems.

    Techniques: Expressing

    Association between CRT, eIF-2a, Ki67 expression and clinicopathological features of advanced endometrial cancer patients after NAC.

    Journal: Oncology Letters

    Article Title: Significance of calreticulin as a prognostic factor in endometrial cancer

    doi: 10.3892/ol.2018.8495

    Figure Lengend Snippet: Association between CRT, eIF-2a, Ki67 expression and clinicopathological features of advanced endometrial cancer patients after NAC.

    Article Snippet: Primary antibodies against CRT (MAB3898), p-eIF2a (AF705) and PERK (AF3999) were purchased from R&D systems.

    Techniques: Expressing